Drug intelligence / Profile preview

Rizfun

Development stage: Preclinical
Lead developer: LYS PHARMA

Overview

Rizfun is a nutritional supplement developed by LYS PHARMA, specifically designed for the infant and toddler nutrition market. Positioned within the company's pediatric pipeline, Rizfun is formulated to support the healthy growth and development of young children by addressing specific nutritional requirements during early life stages. As a nutraceutical, it likely incorporates a blend of essential vitamins, minerals, or probiotics aimed at optimizing gut health, immune function, and physical maturation. The product is part of LYS PHARMA's broader focus on specialized healthcare solutions and nutritional interventions for pediatric populations.

Brand names: Rizfun리즈펀
Other names: Rizfun™

Beyond the preview

Go deeper on Rizfun.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rizfun.

Explore the full profile